In a filing, Harmony Biosciences Holdings Inc revealed its Former Officer JEFFREY G DIERKS acquired Company’s shares for reported $0.2 million on Jun 10 ’25. In the deal valued at $35.98 per share,5,615 shares were bought.
Then, JEFFREY G DIERKS bought 9,844 shares, generating $350,083 in total proceeds.
Before that, JEFFREY G DIERKS bought 2,292 shares. Harmony Biosciences Holdings Inc shares valued at $80,427 were divested by the Former Officer at a price of $35.09 per share.
Deutsche Bank began covering HRMY with “Buy” recommendation on February 11, 2025. H.C. Wainwright started covering the stock on December 17, 2024. It rated HRMY as “a Buy”.
Price Performance Review of HRMY
On Tuesday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock jump 0.37% to $34.84. Over the last five days, the stock has gained 6.38%. Harmony Biosciences Holdings Inc shares have risen nearly 4.56% since the year began. Nevertheless, the stocks have risen 1.25% over the past one year. While a 52-week high of $41.61 was reached on 01/21/25, a 52-week low of $26.47 was recorded on 04/09/25.
Levels Of Support And Resistance For HRMY Stock
The 24-hour chart illustrates a support level at 34.33, which if violated will result in even more drops to 33.81. On the upside, there is a resistance level at 35.16. A further resistance level may holdings at 35.47.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2025-06-13, growing by 1.15 million shares to a total of 3.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.55 million shares. There was a rise of 31.15%, which implies that there is a positive sentiment for the stock.
